Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1982 Jun;79(12):3808–3812. doi: 10.1073/pnas.79.12.3808

Activation of a suppressor T-cell pathway by interferon.

T M Aune, C W Pierce
PMCID: PMC346517  PMID: 6179085

Abstract

In addition to antiviral activities, murine fibroblast (type I) interferon (IFN-beta) suppresses immune responses. The mechanism(s) by which IFN-beta suppresses antibody responses by murine spleen cells to sheep erythrocytes in vitro has been investigated. IFN-beta-mediated suppression is partially or completely prevented by catalase, 2-mercaptoethanol, and certain peroxidase substrates (ascorbic acid, potassium iodide, and tyrosine). These same reagents also block suppression by mediators from concanavalin A-activated murine suppressor T cells, soluble immune response suppressor (SIRS)/macrophage-derived suppressor factor (Mphi-SF), and act by inactivating Mphi-SF or preventing formation of Mphi-SF from SIRS. Therefore, these experiments suggested that IFN-beta may act by inducing production of a molecule that has properties of SIRS. Treatment of spleen cells with IFN-beta leads to generation of a population of Lyt2+ suppressor T cells that acts by elaborating a soluble factor. This IFN-beta-induced suppressor T-cell factor (IFN-TsF) has properties in common with SIRS. First, both SIRS and IFN-TsF suppress antibody responses with the same characteristic kinetic pattern; responses initiate normally but prematurely terminate after day 4 of culture. Second, IFN-TsF and SIRS are of comparable size (45,000-55,000 daltons) and are converted to Mphi-SF by low (1 microM) concentrations of H2O2 or by macrophages. Third, Mphi-SF obtained from IFN-TsF or SIRS is inactivated by similar concentrations of reagents such as ascorbic acid, potassium iodide, and 2-mercaptoethanol. These data show that the immunosuppressive properties of IFN-beta are due, at least in part, to its ability to activate suppressor T cells that produce mediators that appear to be analogous to those in the SIRS/Mphi-SF pathway of immunosuppression.

Full text

PDF
3808

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aune T. M., Pierce C. W. Conversion of soluble immune response suppressor to macrophage-derived suppressor factor by peroxide. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5099–5103. doi: 10.1073/pnas.78.8.5099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aune T. M., Pierce C. W. Identification and initial characterization of a nonspecific suppressor factor (macrophage-SF) produced by soluble immune response suppressor (SIRS)-treated macrophages. J Immunol. 1981 Nov;127(5):1828–1833. [PubMed] [Google Scholar]
  3. Aune T. M., Pierce C. W. Mechanism of action of macrophage-derived suppressor factor produced by soluble immune response suppressor-treated macrophages. J Immunol. 1981 Jul;127(1):368–372. [PubMed] [Google Scholar]
  4. Gresser I., Maury C., Brouty-Boyé D. Mechanism of the antitumour effect of interferon in mice. Nature. 1972 Sep 15;239(5368):167–168. doi: 10.1038/239167a0. [DOI] [PubMed] [Google Scholar]
  5. Herberman R. R., Ortaldo J. R., Bonnard G. D. Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity. Nature. 1979 Jan 18;277(5693):221–223. doi: 10.1038/277221a0. [DOI] [PubMed] [Google Scholar]
  6. ISAACS A., LINDENMANN J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci. 1957 Sep 12;147(927):258–267. doi: 10.1098/rspb.1957.0048. [DOI] [PubMed] [Google Scholar]
  7. Johnson H. M., Blalock J. E. Interferon immunosuppression: mediation by a suppressor factor. Infect Immun. 1980 Aug;29(2):301–305. doi: 10.1128/iai.29.2.301-305.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Johnson H. M. Differentiation of the immunosuppressive and antiviral effects of interferon. Cell Immunol. 1978 Mar 15;36(2):220–230. doi: 10.1016/0008-8749(78)90266-6. [DOI] [PubMed] [Google Scholar]
  9. Johnson H. M., Smith B. G., Baron S. Inhibition of the primary in vitro antibody response by interferon preparations. J Immunol. 1975 Jan;114(1 Pt 2):403–409. [PubMed] [Google Scholar]
  10. Khesin Ia E., Voronina F. V., Marchenko V. I., Rusanova N. A., Balandin I. G. Morfologicheskie, tsitokhimicheskie i biokhimicheskie izmeneniia v peritoneal'nykh makrofagakh (normal'nykh, aktivirovannykh i tolerantnykh) v protsesse interferonoobrazovaniia. Vopr Virusol. 1973 May-Jun;18(3):302–308. [PubMed] [Google Scholar]
  11. Lindahl-Magnusson P., Leary P., Gresser I. Interferon inhibits DNA synthesis induced in mouse lymphocyte suspensions by phytohaemagglutinin or by allogeneic cells. Nat New Biol. 1972 May 24;237(73):120–121. doi: 10.1038/newbio237120a0. [DOI] [PubMed] [Google Scholar]
  12. Lindahl P., Leary P., Gresser I. Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. Proc Natl Acad Sci U S A. 1972 Mar;69(3):721–725. doi: 10.1073/pnas.69.3.721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mage M. G., McHugh L. L., Rothstein T. L. Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin. J Immunol Methods. 1977;15(1):47–56. doi: 10.1016/0022-1759(77)90016-3. [DOI] [PubMed] [Google Scholar]
  14. Pacheco D., Falcoff R., Catinot L., Floc'h F., Werner G. H., Falcoff E. Inhibitory effect of interferon on DNA and RNA synthesis in murine spleen cells stimulated by lectins. Ann Immunol (Paris) 1976 Mar-Apr;127(2):163–171. [PubMed] [Google Scholar]
  15. Pierce C. W., Johnson B. M., Gershon H. E., Asofsky R. Immune responses in vitro. 3. Development of primary gamma-M, gamma-G, and gamma-A plaque-forming cell responses in mouse spleen cell cultures stimulated with heterologous erythrocytes. J Exp Med. 1971 Aug 1;134(2):395–416. doi: 10.1084/jem.134.2.395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pierce C. W., Kapp J. A. Regulation of immune responses by suppressor T cells. Tohoku J Exp Med. 1976;5:91–143. [PubMed] [Google Scholar]
  17. Rich R. R., Pierce C. W. Biological expressions of lymphocyte activation. 3. Suppression of plaque-forming cell responses in vitro by supernatant fluids from concanavalin A-activated spleen cell cultures. J Immunol. 1974 Apr;112(4):1360–1368. [PubMed] [Google Scholar]
  18. Schultz R. M., Papamatheakis J. D., Chirigos M. A. Interferon: an inducer of macrophage activation by polyanions. Science. 1977 Aug 12;197(4304):674–676. doi: 10.1126/science.877584. [DOI] [PubMed] [Google Scholar]
  19. Tadakuma T., Pierce C. W. Mode of action of a soluble immune response suppressor (SIRS) produced by concanavalin a-activated spleen cells. J Immunol. 1978 Feb;120(2):481–486. [PubMed] [Google Scholar]
  20. Thorbecke G. J., Friedman-Kien A. E., Vilcek J. Effect of rabbit interferon on immune responses. Cell Immunol. 1974 May;12(2):290–295. doi: 10.1016/0008-8749(74)90081-1. [DOI] [PubMed] [Google Scholar]
  21. Trinchieri G., Santoli D. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med. 1978 May 1;147(5):1314–1333. doi: 10.1084/jem.147.5.1314. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES